Drug for curing rectal cancer

A technology of rectal cancer and agrimony, which is applied in the field of medicine for rectal cancer, can solve the problems of affecting the quality of life of patients and the prognosis, endangering the life of patients, and not obvious efficacy, etc., achieving remarkable curative effect, low price and good effect Effect

Inactive Publication Date: 2008-10-15
殷世勇
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Rectal cancer, as a kind of malignant tumor, seriously endangers the life of patients. Now Western medicine generally treats rectal cancer through surgery and chemotherapy. Surgery and chemotherapy are not only expensive, but also cause great trauma to the patient's body and mind. Seriously affect the patient's quality of life and prognosis
In traditional Chinese medicine, although there are also drugs for the treatment of rectal cancer, most of them are slow to take effect and the effect is not obvious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach 1

Embodiment approach 2

Embodiment approach 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug for treating rectum cancer. The drug is prepared by decocting agrimony, 100-140g and jujube, 90-110g into thick decoction with water. Compared with surgical or other pharmaceutical treatment methods adopted in the modern medicine, the drug has the advantages that: (1) the drug has no toxic and side effect and can be administered by the elderly, children and pregnant women for a long time, and it has no any influence on normal development of a fetus; (2) the drug is safe, economic, comfortable in administration, remarkable in therapeutic effect and low in cost (2 Yuan per dosage); (3) the drug has short treatment period and rapid and good effect, an overall treatment period is of only 90 days; and (4) compared with surgical or other pharmaceutical treatment methods, the treatment with the drug is safe and reliable, low in cost and convenient in administration and is easily accepted by patients.

Description

A medicine for rectal cancer technical field The invention relates to a medicine for treating rectal cancer. Background technique Rectal cancer, as a kind of malignant tumor, seriously endangers the life of patients. Now Western medicine generally treats rectal cancer through surgery and chemotherapy. Surgery and chemotherapy are not only expensive, but also cause great trauma to the patient's body and mind. Seriously affect the patient's quality of life and prognosis. In traditional Chinese medicine, although there are also drugs for the treatment of rectal cancer, most of them take effect slowly and the effect is not obvious. Contents of the invention The invention overcomes the above disadvantages and provides a medicine for treating rectal cancer with remarkable curative effect, low cost and simple formula. The technical solution adopted by the present invention to solve the technical problems is: a medicine for treating rectal cancer, which is made of agrimony, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/73A61P35/00A61P1/00
Inventor 殷世勇
Owner 殷世勇
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products